Q2 2019 8-K

Company

ENANTA PHARMACEUTICALS INC

Filed

May 7, 2019

Period of Report

May 7, 2019

Accession Number

0001564590-19-016489

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →